The International Association for the Study of Lung Cancer lung cancer staging project: proposals regarding the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor, node, metastasis classification for lung cancer
- PMID: 18090577
- DOI: 10.1097/JTO.0b013e31815bdc0d
The International Association for the Study of Lung Cancer lung cancer staging project: proposals regarding the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor, node, metastasis classification for lung cancer
Abstract
Background: Small cell lung cancer (SCLC) is usually classified using the limited and extensive definition. The tumor, node, metastasis (TNM) classification should also be applicable to SCLC, but it has only been reported in small surgical series. The current analysis looks to the impact of the TNM system on the clinical staging of SCLC and of the new International Association for the study of Lung Cancer (IASLC) proposals.
Methods: Using the IASLC database, survival analyses were performed for clinically staged patients. Prognostic groups were compared, and the new IASLC TNM proposals were applied to this population and to the Surveillance, Epidemiology, and End Results (SEER) database.
Results: The IASLC database contained 12,620 eligible cases of small cell histology. TNM staging was available for 8088 patients. Survival was directly correlated to both T and N category. Differences were more pronounced in patients without mediastinal or supraclavicular nodal involvement. Stage grouping using the sixth edition of TNM also differentiates survival except between IA and IB. Patients with pleural effusion regardless of the cytology have an intermediate prognosis between limited and extensive disease. The IASLC proposals for the seventh edition of the TNM classification also apply to this series of SCLC and to the SEER database.
Conclusion: TNM staging is recommended for SCLC, and stratification by stage I-III should be incorporated in clinical trials of early-stage disease. Further studies are needed to clarify the impact of pleural effusion and the extent of N3 disease.
Similar articles
-
The IASLC Lung Cancer Staging Project: proposals regarding the relevance of TNM in the pathologic staging of small cell lung cancer in the forthcoming (seventh) edition of the TNM classification for lung cancer.J Thorac Oncol. 2009 Sep;4(9):1049-59. doi: 10.1097/JTO.0b013e3181b27799. J Thorac Oncol. 2009. PMID: 19652623
-
The applicability of the proposed IASLC staging revisions to small cell lung cancer (SCLC) with comparison to the current UICC 6th TNM Edition.J Thorac Oncol. 2009 Mar;4(3):300-10. doi: 10.1097/JTO.0b013e318194a355. J Thorac Oncol. 2009. PMID: 19156001
-
The IASLC Lung Cancer Staging Project: proposals for the inclusion of broncho-pulmonary carcinoid tumors in the forthcoming (seventh) edition of the TNM Classification for Lung Cancer.J Thorac Oncol. 2008 Nov;3(11):1213-23. doi: 10.1097/JTO.0b013e31818b06e3. J Thorac Oncol. 2008. PMID: 18978555
-
The revised TNM staging system for lung cancer.Ann Thorac Cardiovasc Surg. 2009 Feb;15(1):4-9. Ann Thorac Cardiovasc Surg. 2009. PMID: 19262443 Review.
-
Non-small cell lung cancer staging: proposed revisions to the TNM system.Cancer Imaging. 2008 Sep 30;8(1):181-5. doi: 10.1102/1470-7330.2008.0029. Cancer Imaging. 2008. PMID: 18824424 Free PMC article. Review.
Cited by
-
LC-MS/MS-Based Quantitative Proteomics Analysis of Different Stages of Non-Small-Cell Lung Cancer.Biomed Res Int. 2021 Feb 26;2021:5561569. doi: 10.1155/2021/5561569. eCollection 2021. Biomed Res Int. 2021. PMID: 33728331 Free PMC article.
-
An Elevated Peripheral Blood Monocyte-to-Lymphocyte Ratio Predicts Poor Prognosis in Patients with Primary Pulmonary Lymphoepithelioma-Like Carcinoma.PLoS One. 2015 May 7;10(5):e0126269. doi: 10.1371/journal.pone.0126269. eCollection 2015. PLoS One. 2015. PMID: 25950432 Free PMC article.
-
Prognostic significance of serum osteopontin levels in small cell lung cancer.BMC Pulm Med. 2020 Sep 1;20(1):235. doi: 10.1186/s12890-020-01242-3. BMC Pulm Med. 2020. PMID: 32873264 Free PMC article.
-
Evaluation of PD-L1 expression on circulating tumour cells in small-cell lung cancer.Transl Lung Cancer Res. 2022 Mar;11(3):440-451. doi: 10.21037/tlcr-21-819. Transl Lung Cancer Res. 2022. PMID: 35399573 Free PMC article.
-
Treatment options for small cell lung cancer - do we have more choice?Br J Cancer. 2010 Feb 16;102(4):629-38. doi: 10.1038/sj.bjc.6605527. Epub 2010 Jan 26. Br J Cancer. 2010. PMID: 20104223 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical